Login
← Go Back
Sun Pharmaceutical Industries
SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com
Stock Price vs Company Growth
1d
0.2%
1w
0.7%
1m
0.2%
3m
1.7%
6m
5.1%
1y
2.2%
5y
23.5%
10y
8.2%
all
17.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,715 0.2%
1,573
1,832
Company Overview
Sales
56,809 Cr
Growth: 8.8%
Profit after Tax
10,915 Cr
Growth: 4.5%
Large Cap
4,11,402 Cr
P/E: 37.7x
Industry P/E: 29.7x
Fundamentals
Sales (Cr) ₹ 56,809
Growth 8.8%
EBITDA 28.8%
P/S 7.2x
Dividend 0.9%
P/E 37.7x
Book Value ₹ 338
PEG Ratio 4.3x
ROE 14.3%
P/B 5.1x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
7.37 %
Icici Prudential Value Discovery Fund And Various Fund Accounts
3.68 %
Sbi-Etf Nifty 50 And Various Fund Accounts
1.94 %
Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts
1.37 %
Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts
1.24 %
Promoters
Shanghvi Finance Private Limited
40.3 %
Dilip.S.Shanghvi
9.6 %
Aditya Medisales Limited
1.67 %
Raksha S.Valia
1.2 %
Sudhir V.Valia
0.6 %
Others
Llp
2.89 %
Lakshdeep Investments & Finance (P) Ltd.
1.18 %
Iepf
0.08 %
Increase    Decrease    No change
Company Profile Detailed
The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.
Belongs to (57 Indices) view more
Investors (337)
subson
shanghvi...
varsha.k...
Followers (136)
bharath....
kiran198...
anil